Losartan represents a new class of antihypertensive drugs that specifically target angiotensin II receptors, offering a direct approach to treating hypertension and potentially preventing cardiovascular and renal diseases.
No takes yet. Share an insight, caveat, or question.
Losartan offers targeted ARB therapy for hypertension; leaves open comparative outcome trials versus newer agents.
Tallant et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: